Richard K. Matros - 31 Aug 2026 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Reporting relationship: Chair, CEO and President, Director
Issuer ticker: SBRA
Reported as of: 31 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2026, 17:28:19 UTC
Prior SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Costa, as Attorney-in-Fact

Key filing fact

Richard K. Matros filed Form 4 for Sabra Health Care REIT, Inc. (SBRA) on 02 Sep 2026.

Key facts

This page summarizes Richard K. Matros's Form 4 filing for Sabra Health Care REIT, Inc. (SBRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 17:28.

Change

Previous filing in this sequence was filed on 02 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001184158 Primary reporting owner

MATROS RICHARD K

Relationship: Chair, CEO and President, Director
Address: C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN
Signature: /s/ Michael Costa, as Attorney-in-Fact
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBRA transaction

Common Stock

Award

Transaction value
Shares: +13,867
Change %: +1.5%
Price: $0.000000^*
Shares after: 956,268
Date: 31 Aug 2026
Ownership: Direct
Footnotes: F1, F2

SBRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,857,686
Date: 31 Aug 2026
Ownership: By R&A Matros Revocable Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

Footnote F2

Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney